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Abstract cDNA for a novel proton/organic cation transporter, 
OCTN1, was cloned from human fetal liver and its transport 
activity was investigated. OCTN1 encodes a 551-amino acid 
protein with 11 transmembrane domains and one nucleotide 
binding site motif. It is strongly expressed in kidney, trachea, 
bone marrow and fetal liver and in several human cancer cell 
lines, but not in adult liver. When expressed in HEK293 cells, 
OCTN1 exhibited saturable and pH-dependent [3H]tetraethyl 
ammonium uptake with higher activity at neutral and alkaline 
pH than at acidic pH. Furthermore, treatment with metabolic 
inhibitors reduced the uptake, which is consistent with the 
presence of the nucleotide binding site sequence motif. Although 
its subcellular localization and detailed functional characteristics 
are not clear at present, OCTN1 appears to be a novel proton 
antiporter that functions for active secretion of cationic 
compounds across the renal epithelial brush-border membrane. 
It may play a role in the renal excretion of xenobiotics and their 
metabolites. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Many xenobiotics that bear ionizable groups exist as anions 
or cations at physiological pH. It seems reasonable to suppose 
that they are transported across membranes via specialized 
carrier-mediated transport mechanisms to be excreted into 
urine or bile, and the existence of closely related transporters 
in both organs has been suggested [1,2]. The transport systems 
have been empirically classified into three groups specific to 
anionic, cationic and neutral compounds and functionally 
subdivided in more detail. It has been established that organic 
cationic compounds are actively secreted from blood to urine 
across the renal tubular epithelial cells via multiple transport 
mechanisms, including a membrane potential-dependent 
transporter and a proton/organic cation antiporter in baso-
lateral and brush-border membranes, respectively [1,3]. The 
application of molecular biological techniques has been help-
ful in characterizing the transporters. Two renal membrane 
transporters, OCT1 and OCT2, which exhibit membrane po-
tential dependence, have been cloned from rat, porcine kid-
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ney-derived LLC-PK1 cells and human [4-9]. Although Grün-
demann et al. [6] suggested that OCT2 is an apical-type trans-
porter on the basis of its susceptibility to specific transport 
inhibitors, Okuda et al. [5] found a negligible pH dependence 
of rat OCT2 and suggested that it is a basolateral - but not an 
apical - membrane transporter. The human counterpart of 
OCT2 was also cloned recently and was implicated in pH-
independent, membrane potential-dependent transport at the 
luminal surface of distal tubules [9]. Accordingly, human 
OCT2 was presumed to function for the reabsorption of en-
dogenous organic cations such as choline, as well as xenobi-
otics. So far, however, molecular identification of a proton/ 
organic cation antiporter in the renal apical membrane, which 
would be important for the efficient elimination of organic 
cations into urine, has not been reported. 
Our interest has been focused on the regulation of drug 
disposition in the body and the targeting of drugs to specific 
tissues by utilizing specialized transporter functions in the 
tissues [10-12]. In the present study, we cloned from human 
fetal liver a cDNA for a novel organic cation transporter 
(OCTN1), which carries a nucleotide binding site sequence 
motif. It is strongly expressed in kidney and transports organ-
ic cations such as tetraethyl ammonium (TEA) in a pH-de-
pendent and metabolic inhibitor-susceptible manner, strongly 
suggesting that OCTN1 is a renal proton/organic cation anti-
porter functioning at the renal epithelial apical membrane. 
2. Materials and methods 
2.1. Construction of cDNA library and isolation of human OCTN1 
and Northern blot analysis 
A subtracted cDNA library was constructed by suppression sub-
tractive hybridization [13] using a PCR-Select cDNA Subtraction kit 
(Clontech, Palo Alto, CA, USA). Double-stranded cDNAs synthe-
sized from human fetal and adult liver polyA+ RNA were used as 
tester and driver, respectively. After two rounds of hybridization, 
cDNA fragments derived from differentially expressed genes were 
amplified by suppression polymerase chain reaction, and cloned into 
pT7-Blue-T (Novagen, Madison, WI, USA) by the ТА cloning meth-
od. The resulting cDNA clones were subjected to random sequencing 
to generate ESTs. BLAST analysis identified one EST, OCTN1, which 
has an open reading frame with significant sequence similarity to 
known organic cation transporters. A cDNA insert of this clone 
was then used as a probe to screen a human fetal liver cDNA library 
(Clontech). Eight overlapping positive clones were isolated from 
about 8xl05 plaques and the whole sequence of OCTN1 was deter-
mined by sequencing cDNA inserts of these clones. Multiple tissue 
Northern blots containing mRNA from human fetal and adult tissues 
and cancer cell lines (Clontech) were probed with cDNA fragments 
corresponding to the carboxyl-terminal half of OCTN1 cDNA labeled 
with [32P]dCTP by the random primer method. The probes were hy-
bridized in ExpressHyb Hybridization Solution (Clontech) at 68°C for 
1 h. The blots were then washed in 2XSSC containing 0.1% SDS at 
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room temperature for 60 min with several changes of the buffer, and 
twice for 20 min in 0.1 XSSC containing 0.1% SDS at 50°C. 
2.2. Transport experiments by transient expression in HEK293 cells 
Human OCTNl cDNA was subcloned into EcoKl sites of the ex-
pression vector pcDNA3 (Invitrogen, San Diego, CA, USA). The 
construct pcDNA3/OCTNl was used to transfect HEK293 cells (Jap-
anese Cancer Research Resources Bank, Tokyo, Japan) according to 
the calcium phosphate precipitation method [14]. HEK293 cells were 
routinely grown in Dulbecco's modified Eagle's medium containing 
10% fetal calf serum (Gibco, Grand Island, NY), penicillin, and strep-
tomycin in a humidified incubator at 37°C and 5% CO2. After 24 h 
cultivation of HEK293 cells in 10-cm dishes, pcDNA3/OCTNl or 
pcDNA3 vector alone was transfected by adding 10 μg of the plasmid 
DNA per dish. At 48 h after transfection, the cells were harvested and 
suspended in transport medium containing 125 mM NaCl, 4.8 mM 
KC1, 5.6 mM D-glucose, 1.2 mM CaCl2, 1.2 mM KH 2P0 4 , 1.2 mM 
MgSC>4 and 25 mM HEPES (pH 7.4). This suspension and a solution 
of a radiolabeled test compound in the transport medium were each 
incubated at 37°C for 10 min, then transport was initiated by mixing 
them. At appropriate times, 200-μ1 aliquote of the mixture were with-
drawn and the cells were separated from the transport medium by 
centrifugal filtration through a layer of a mixture of silicon oil and 
liquid paraffin with a density of 1.03. Each cell pellet was solubilized 
in 3 N KOH, and neutralized with HC1, and the associated radio-
activity was measured by means of a liquid scintillation counter. 
When transport was measured at an acidic or alkaline pH, MES 
and Tris were used instead of HEPES to maintain the desired pH, 
respectively. Cellular protein content was determined according to the 
method of Lowry et al. [15]. 
Fig. 1. Amino acid sequence (A) and hydropathy plot (В) of human OCTNl. Potential 7V-glycosylation sites and protein kinase С phosphoryl-
ation sites are indicated by asterisks and plus signs, respectively. Putative transmembrane domains (TM) are indicated by lines and are num-
bered. The sugar transporter protein signature and nucleoside binding site sequence motif are boxed and highlighted, respectively. 
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Fig. 2. Northern blot analysis of human OCTNl. Commercially available hybridization-ready polyA+ RNA blots were probed with an internal 
fragment of OCTNl cDNA. The sizes of hybridizing bands were determined using RNA standards. PBL, peripheral blood leukocyte; G361, 
melanoma; A549, lung carcinoma; SW480, colorectal adenocarcinoma; Raji, Burkitt's lymphoma; HeLa cell S3, HeLa cell line; HL-60, pro-
myelocytic leukemia. 
2.3. Materials 
[l-14C]Tetraethyl ammonium bromide (0.124 GBq/mmol), 
[14C]inulin (185 MBq/g), 3H20 (37 MBq/g), and [a-32P]dCTP were 
purchased from New England Nuclear (Boston, MA, USA). pcDNA3 
was obtained from Invitrogen. Multiple tissue Northern blots and the 
PCR-Select cDNA subtraction kit were purchased from Clontech. All 
other enzymes and reagents for molecular biology were purchased 
from Takara (Otsu, Japan), Toyobo (Osaka, Japan) and Wako Pure 
Chemical Industries (Osaka). 
3. Results 
3.1. Sequence and tissue distribution of OCTNl 
Fig. 1A shows the predicted amino acid sequence of the 
human organic cation transporter, OCTNl. The cloned 
OCTNl cDNA consists of 2135 nucleotide and contains an 
open reading frame encoding a 551-amino acid residue protein 
(GenBank accession number AB007448). Hydropathy analysis 
according to Kyte and Doolittle [16] predicted that OCTNl 
has 11 putative membrane-spanning domains, four 7V-glyco-
sylation sites, and five protein kinase С phosphorylation sites 
(Fig. IB). OCTNl is unique in having a nucleotide binding 
site sequence motif and a sugar transport protein signature. 
Similarities of human OCTNl with rat OCT1 [4], rat OCT2 
[5], human OCT1 [8] and human OCT2 [9] in amino acid 
sequence were 32%, 33%, 31%o, and 33%>, respectively. Accord-
ingly, human OCTNl is considered to be a member of the 
organic cation transporter family. 
The tissue distribution of human OCTNl was studied by 
Northern blot analysis as shown in Fig. 2. Human OCTNl 
was originally cloned from a human fetal liver cDNA library 
as a fetal liver-specific clone. It was also detected in several 
other fetal tissues, including kidney and lung. In adult, strong 
signals were observed in kidney, trachea, and bone marrow 
and weak signals in skeletal muscle, prostate, lung, pancreas, 
placenta, heart, uterus, spleen, and spinal cord. Interestingly, 
specific bands which correspond to human OCTNl were ob-
served in several human cancer cell lines, including lung car-
cinoma A459, colorectal adenocarcinoma SW480, myeloge-
nous leukemia K-562, and HeLa cell S3. 
3.2. Transport activity of OCTNl in HEK293 cells 
The time course of uptake of [14C]TEA by HEK293 cells 
transfected with OCTNl or expression vector pcDNA3 alone 
was studied (Fig. 3). The uptake of [14C]TEA at pH 7.4, ex-
pressed as the cell/medium ratio obtained by dividing the 
amount of [14C]TEA taken up by the cells by its concentration 
in the transport medium, increased time-dependently in 
OCTNl-transfected cells, whereas the uptake by the cells 
transfected with pcDNA3 vector alone (designated Mock) ex-
hibited a negligible increase with time. In OCTNl-transfected 
cells, the uptake of TEA was linear up to 5 min and reached a 
steady-state. The OCTNl-derived steady-state uptake is more 
than 20 μΐ/mg protein. Since the intracellular space of 
HEK293 cells obtained as the difference between the uptakes 
of 3 H 2 0 and [14C]inulin was determined to be 6.3 μΐ/mg pro-
tein in the present study, [14C]TEA is apparently accumulated 
concentratively within the cells. 
Fig. 4 shows the concentration dependence of TEA uptake 
by OCTNl obtained after subtraction of the Mock uptake. 
The Eadie-Hofstee plot (Fig. 4, inset) gave a single straight 
line, suggesting the participation of a single functional binding 
site for TEA on OCTNl. By non-linear least-squares analysis, 
values of the maximum uptake rate (VmllK) of 6.68 ±0.345 
i» 
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Fig. 3. Time course of [14C]TEA uptake by OCTNl-transfected 
HEK293 cells. Uptake of [14C]TEA (60 μΜ) by OCTNl- (closed 
circles) and pcDNA3 vector-transfected (open circles) HEK293 cells 
was measured at pH 7.4 and 37°C. The results are shown as means 
and S.E.M. of three determinations. 
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Fig. 4. Concentration dependence of TEA uptake by OCTNl-trans-
fected HEK293 cells. Uptake at various concentrations of TEA was 
measured at pH 7.4 and 37°C for 3 min. The results show the val-
ues after subtraction of the Mock uptake. Inset: Eadie-Hofstee plot 
of the saturable uptake of TEA. 
Fig. 5. Effect of pH on [14C]TEA uptake by OCTNl-transfected 
HEK293 cells. Uptake of [14C]TEA (60 μΜ) by OCTNl (closed 
circles) and pcDNA3 vector-transfected (open circles) HEK293 cells 
was measured at 37°C for 3 min. The results are shown as means 
and S.E.M. of three determinations. 
nmol/3 min/mg protein and half-saturation concentration 
(Km) of 0.436 ±0.041 mM were obtained. 
Fig. 5 shows the pH dependence of [14C]TEA uptake by 
OCTNl-transfected cells. When the pH in the transport me-
dium was acidic (pH 6.0), OCTNl-mediated uptake of 
[14C]TEA was decreased to about 30% of those at neutral 
and alkaline pH, whereas no significant change in the uptake 
of [14C]TEA was observed in Mock. Furthermore, compara-
ble uptakes were observed at neutral and alkaline pH. When 
cellular ATP was depleted by pretreatment with metabolic 
inhibitors, sodium azide, sodium fluoride and 3-O-methylglu-
cose, which can decrease cellular ATP level to about 10% of 
the control [17], the uptake of [14C]TEA by OCTNl obtained 
after correction of Mock uptake was decreased to 52-62% of 
the control at all pH values tested (Table 1). Accordingly, 
transport by OCTNl is suggested to occur at least partially 
through a primary active process, which is consistent with the 
nucleotide binding site motif expected from its amino acid 
sequence. In ATP-depleted cells, a more marked pH depend-
ence of OCTNl activity was observed compared with that of 
uptake by the normal non-ATP-depleted cells. 
4. Discussion 
In 1994, the first renal organic cation transporter OCT1 was 
isolated from rat kidney by expression cloning [4]. As a ho-
mologue of OCT1, OCT2 from rat and their counterparts 
from human kidney and liver and a porcine kidney-derived 
cell line, LLC-PK1, were isolated [5-9]. Rat OCT1 is present 
in several tissues, rich in kidney, liver and intestine, and likely 
to function at the basolateral membrane of renal tubular epi-
thelial cells, considering its pH-independent and membrane 
potential-dependent transport characteristics. The distribution 
of rat OCT2 is limited to kidney and, to a minor extent, brain. 
Gründemann et al. [6] suggested that rat OCT2 may be an 
apical-type transporter on the basis of its susceptibility to 
specific cation transport inhibitors and pH-dependent trans-
port activity. However, Okuda et al. [5] reported a discrepant 
result, i.e. pH independence of rat OCT2, so further study on 
the localization within the kidney and the functional charac-
teristics of rat OCT2 is needed. As for human OCT1 and 
OCT2, they are strongly expressed in liver and kidney, respec-
tively, and both of them exhibit membrane potential-depend-
ent transport activity [8,9]. Although an immunohistochemical 
study indicated that OCT2 is present at the apical membrane 
of kidney, it is expected to have a role in reabsorption from 
the renal tubular lumen, since it exhibits membrane potential-
dependent transport activity [9]. Thus, no apically expressed 
organic cation/proton antiporter has yet been clearly identi-
fied. 
In the present study, a novel cDNA clone which was ex-
pected to encode an organic cation transporter, because of the 
relatively high similarity of the predicted amino acid sequence 
to those of known rat and human organic cation transporters, 
OCT1 and OCT2. We transiently expressed OCTNl in 
HEK293 cells and the transport activity was examined using 
TEA as a model organic cation. As can be seen in Figs. 3-5, 
OCTNl exhibited saturable, metabolic energy-dependent, and 
pH-sensitive transport of [3H]TEA with higher activity at neu-
tral and alkaline pH than at acidic pH. The Michaelis con-
stant obtained at pH 7.4, 436 μΜ, is high compared with 
those of previously cloned ОСТ family members, for which 
the Km values range from 20 to 100 μΜ, including human 
[4,6,8,9], and the inhibition constant K, (163 μΜ) of TEA 
for the transport of l-methyl-4-phenylpyridinium by human 
OCT1 [7]. Accordingly, OCTNl has lower affinity for TEA 
than those of previously isolated transporters and seems to be 
a novel organic cation transporter. The Km value of 0.21 mM 
Table 1 
Effect of ATP depletion on [14C]TEA uptake by OCTNl-transfected HEK293 cells 
Uptake of [14C]TEA (μ1/2 min/mg protein) 
pH 6.0 
7.4 
8.4 
OCTNl-transfected 
Normal 
9.33 ±0.35 
14.51 ±0.11 
14.0 ±0.36 
ATP-depleted 
6.46 ±0.30* 
11.2 ±0.93* 
10.4 ±0.22* 
Mock 
Normal 
4.63 ±0.19 
4.45 ± 0.43 
4.83 ±0.37 
ATP-depleted 
4.00 ±0.21 
4.64 ±0.19 
4.71 ±0.49 
Uptake of [14C]TEA (60 uM) by OCTNl- and pcDNA3 vector-transfected HEK293 cells was measured at 37°C for 2 min. The procedure for ATP 
depletion is described in the text. Each value represents the mean ± S.E.M. of three determinations. * Significantly different from normal not 
ATP-depleted cells. 
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for pH-dependent TEA uptake was obtained by using isolated 
renal brush-border membrane vesicles from rat [18], and this 
is close to the Km value obtained in the present study. 
Although no Km value for human renal transport of TEA is 
yet available, it is worth noting that the available Km values 
for renal basolateral transporters so far identified are distinct 
from that obtained in the present study. TEA uptake by 
HEK293 transfected with OCTN1 was clearly pH-dependent, 
whereas the uptake of TEA by Mock showed little variation 
at pH values between 6.0 and 8.4. This observation strongly 
suggests that OCTN1 is a novel organic cation transporter, 
which may operate at the apical membrane of renal epithelial 
cells. Uptake at pH 8.4 was comparable with that at pH 7.4. 
Maegawa et al. reported that there is an optimal pH for a 
proton/organic cation antiporter of around pH 7 and the ac-
tivity of the antiporter is regulated by pH as well as proton 
gradient as the driving force [19]. The observed pH depend-
ence of OCTN1 may be explained by the presence of such an 
optimal pH. Both an outward proton gradient and the pH in 
the uptake medium may be important, as a driving force for 
OCTN1 and for regulation of transport activity, respectively. 
OCTN1 possesses a nucleo tide binding sequence motif, 
which suggests it may be an ATP-dependent transporter. As 
shown in Table 1, by depleting ATP with metabolic inhibitors, 
uptake of [14C]TEA was partially decreased. The effect of 
ATP depletion was most evident at pH 6.0, where only 52% 
of the activity of the control remained, whereas approximately 
62% of the control activity remained at neutral and alkaline 
pH. These results might suggest that ATP dependence was 
minimal in the presence of a proton gradient, as observed at 
pH 7.4 and 8.4, whereas at acidic pH the transport largely 
depends on ATP. ATP-dependent transport of organic cations 
at the apical membrane of kidney has been reported to func-
tion for reabsorption of endogenous cations and some xeno-
biotics [20]. It was suggested that the ATP binding site of the 
transporter is localized at the apical surface, since supply of 
ATP, for which the membrane permeability is negligible, from 
the extravesicular transport medium is effective to energize 
TEA uptake by renal brush-border membrane vesicles which 
are oriented right-side out. From our hydropathy analysis and 
the location of possible iV-glycosylation sites of OCTN1, the 
putative nucleotide binding site may be located at the extra-
cellular portion between transmembrane domains 3 and 4 of 
OCTN1. Accordingly, OCTN1 may be the transporter re-
sponsible for the ATP-dependent reabsorption, as previously 
suggested. However, it is still necessary to rule out the possi-
bility that the apparent metabolic energy dependence observed 
in the present study may be ascribed to a reduced ability to 
maintain a constant intracellular pH owing to the lowered 
ATP content. 
The presence of OCTN1 in several human cancer cell lines 
is interesting, since it may suggest that OCTN1 can regulate 
uptake or efflux of chemotherapeutic compounds in these 
cells. To clarify the clinical significance of OCTN1, it will 
be necessary to elucidate the precise substrate specificity and 
transport directionality of OCTN1. 
In conclusion, we have cloned a cDNA of a novel human 
organic cation transporter OCTN1 which is sensitive to pH, 
suggesting that it may be a proton/organic cation antiporter. 
Characteristic features of OCTN1 include a nucleotide bind-
ing sequence motif and the partial dependence of its transport 
activity on metabolic energy. It was found in several human 
cancer cell lines as well as normal kidney, bone marrow and 
trachea, although its physiological role in these tissues re-
mains to be established. Further studies, including subcellular 
localization using antibody and elucidation of the mechanism 
of the pH dependence and metabolic energy-sensitive activity, 
as well as the substrate specificity, are needed to establish the 
physiological importance of this transporter. 
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